With a median follow-up duration of 27.1 mo , improvement in rPFS was statistically significant with abiraterone treatment versus prednisone ( median : 16.5 vs 8.2 mo ; HR : 0.52 [ 95 % CI , 0.45-0 .61 ] ; p < 0.0001 ) .